Understanding how HIV-1 reverse transcription works and its effects
Mechanisms and Consequences of Reverse Transcription in HIV-1 Cores
This study is looking at how the HIV-1 virus makes copies of itself, focusing on a part of the virus that protects its genetic material, to find new ways to help people living with HIV.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-10880552 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind reverse transcription in HIV-1, which is crucial for the virus's ability to replicate and cause AIDS. By studying the HIV-1 capsid, which protects the viral genome, the project aims to uncover how changes to this structure affect the virus's ability to replicate. The research employs advanced biophysical techniques and computational models to analyze the viral cores and their interactions. This could lead to the development of new therapeutic strategies targeting the capsid and improving treatment options for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV-1 who may benefit from novel therapeutic approaches.
Not a fit: Patients who are not infected with HIV-1 or those who have already developed extensive drug resistance may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that more effectively combat HIV-1 and potentially overcome drug resistance.
How similar studies have performed: Previous research has shown promising results in targeting the HIV-1 capsid, indicating that this approach has potential for success.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Aiken, Christopher R — Vanderbilt University Medical Center
- Study coordinator: Aiken, Christopher R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.